scispace - formally typeset
Journal ArticleDOI

Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy

TLDR
carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections, indicating the importance of their concurrent evaluation, especially during chronic studies.
Abstract
The competitive relationship between d-amphetamine induced stereotypy and locomotor activity indicates the importance of their concurrent evaluation, especially during chronic studies. Repeated injection of 0.5, 1.0, 2.5, 5.0, or 7.5 mg/kg d-amphetamine for 36 successive days, in rats continuously exposed to the experimental chambers, produced a progressive augmentation in stereotypy and/or locomotion (depending on dose) during the 3–4 hr interval following injections (post-injection phase). In contrast, dark phase locomotor activity (8–20 hr after each daily injection) was maximally reduced (30–40% of controls) after the first injection of either 5.0 or 7.5 mg/kg d-amphetamine and gradually declined to this level with repeated injection of 1.0 and 2.5 mg/kg. Carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections. Possible mechanisms underlying these behavioral alterations are discussed.

read more

Citations
More filters
Journal ArticleDOI

Effects of acute and repeated administration of N-methyl-d-aspartate (NMDA) into the ventral tegmental area: locomotor activating effects of NMDA and cocaine

TL;DR: In the present study, N-methyl-D-aspartate infused bilaterally into the ventral tegmental area (VTA) produced dose-dependent locomotor activation, consistent with the notion that repeated activation of NMDA receptors is sufficient for the development of behavioral sensitization to NMDA.
Journal ArticleDOI

Suppressive effect of cycloheximide on behavioral sensitization to methamphetamine in mice

TL;DR: The effect of a protein synthesis inhibitor, cycloheximide, on behavioral sensitization to methamphetamine was investigated in mice and it was noted that locomotor activity was significantly higher in mice injected repeatedly with the stimulants alone and in those mice treated with the inhibitor 4 h after the stimulant injection compared to the saline-treated control mice.
Journal ArticleDOI

Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats.

TL;DR: It is demonstrated that stepwise-extended daily access to METH (3, 6, 12, and 24 h) self-administration in rats closely approximates motivational, pharmacokinetic, as well as behavioral patterns of human METH abuse.
Journal ArticleDOI

Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.

TL;DR: It is suggested that endogenous CCK, released during exploratory activity, shapes behavioral responses to amphetamine by acting on both receptor subtypes, and modulates the development of sensitization to Amphetamine.
Journal ArticleDOI

Methamphetamine induces endoplasmic reticulum stress related gene CHOP/Gadd153/ddit3 in dopaminergic cells.

TL;DR: Endoplasmic reticulum stress is demonstrated in a model of presynaptic dopaminergic neurons for the first time and provides new insights into the mechanisms of dopamine toxicity, which might represent one of the most important mechanisms of methamphetamine toxicity and addiction.
References
More filters
Journal Article

Antiamphetamine effects following inhibition of tyrosine hydroxylase

TL;DR: The antiamphetamine effects of α-MT and other tyrosine hydroxylase inhibitors suggest that a critical level of norepinephrine at the receptor is required for amphetamine to exert its customary effects.
Journal ArticleDOI

Role of Catecholamines in the Amphetamine Excitatory Response

A. Randrup, +1 more
- 30 Jul 1966 - 
TL;DR: The advent of α-methyl para-tyrosine3 (α-MPT), which inhibits the in vivo synthesis of 3,4-dihydroxyphenylalanine (DOPA)—the physiological precursor of the catecholamines—offers a new way of investigating this problem.
Related Papers (5)